Tampolay, Leah .
HRN: 23-65-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/05/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/05/2023
09/12/2023
IVT
500mg
Q8
PID
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes